Last $3.77 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 08/8/14 All times are local (Market data is delayed by at least 15 minutes).

balda ag (BALOF) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/8/13 - $7.12
52 Week Low
08/8/14 - $3.77
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BALDA AG (BALOF)

Related News

No related news articles were found.

balda ag (BALOF) Related Businessweek News

No Related Businessweek News Found

balda ag (BALOF) Details

Balda Aktiengesellschaft, through its subsidiaries, develops and manufactures plastic solutions for the medical, optics, electronics, and automotive industries in Germany and internationally. The company operates in two segments, Balda Medical and Balda Technical. The Balda Medical segment manufactures plastic products for the pharmaceutical, diagnostics, and medical technology sectors. This segment offers various handheld devices, including blood glucose meters, finger prickers, inhalers, insertion devices, and tablet dispensers; single-user articles, such as pipettes, cuvettes, veterinary tubes, and racks; packaging products comprising child-proof tubes; and specialized functional assemblies for integration into complex systems. The Balda Technical segment develops and produces high-precision injection-molded plastic solutions for the eyewear, electronics, and automotive industries. This segment’s products include eyeglass frames for sports and lifestyle applications; complex plastics solutions for home audio components; and high-tech plastics products for automotive modules, such as tire pressure check gages. This segment serves manufacturing and consumer goods multinationals, as well as SMEs. The company was founded in 1908 and is headquartered in Bad Oeynhausen, Germany.

Founded in 1908

balda ag (BALOF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

balda ag (BALOF) Key Developments

Balda AG Presents at DVFA 12th Small Cap Conference, Sep-02-2014 05:20 PM

Balda AG Presents at DVFA 12th Small Cap Conference, Sep-02-2014 05:20 PM. Venue: DVFA Center, Mainzer Landstr. 37-039, 60329 Frankfurt am Main, Germany. Speakers: Oliver Oechsle, Chief Operating Officer and Member of Management Board.

Balda AG Reports Preliminary Consolidated Earnings Results for Fiscal 2014; Provides Earnings Guidance for Fiscal 2015

Balda AG reported preliminary consolidated earnings results for fiscal 2014. Consolidated revenue stood at EUR 70.5 million, compared with EUR 59.9 million in the prior-year period, reflecting a 17.7% growth. This increase is predominately attributable to the full consolidation for the first time of the US companies acquired in 2012. The company generated earnings before interest, tax, depreciation and amortization (EBITDA) of around EUR 4.0 million before extraordinary items. After taking into account depreciation, amortization and extraordinary items, loss before interest and tax stood at around EUR 4.6 million. For fiscal 2015, the company aims at an increase to revenues of EUR 73 million to EUR 78 million, provided that currencies will not develop adversely. Further a positive EBIT is expected with a low one-digit EBIT-margin.

Balda AG Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 2014; Reaffirms Earnings Guidance for the Full Year of 2013/2014

Balda AG announced consolidated earnings results for the third quarter and nine months ended March 2014. In the third quarter of 2013/2014 consolidated earnings stood at EUR 16.1 million, after the quarters the total earnings amounted to EUR 51.0 million (year prior: EUR 39.6 million). This rise is attributable to the complete consolidation of the US-acquisitions at the end of 2012. The company generated a profit before interest, tax, depreciation and amortization (EBITDA) from its continuing operations of EUR 1.3 million in the reporting period following a loss of EUR 0.6 million in the previous year. After tax, the group reports EUR 10.4 million of earnings from its continuing operations (comparable period: EUR 11.9 million). With its Balda America segment the company generated EUR 29.2 million sales revenue in the first nine months of 2013/2014 and in the prior year period EUR 11.6 million. In the current reporting period the US companies are fully integrated while in the previous year only three months were consolidated. The segment EBITDA stood at EUR 1.7 million (prior-year period: EUR 0.2 million). The segment Europe generated EUR 21.9 million of sales revenue for the period under review (previous year: EUR 28.0 million). The segment reported a slight loss of EUR 0.3 million at the EBITDA level (prior year period: profit of EUR 0.5 million) due to extraordinary items. General holding company costs led to a slight loss of EUR 0.1 million at the EBITDA level in the other segment after EUR 0.4 million in the previous year. The Management board is retaining the forecasts for the full 2013/2014 year: Assuming that macroeconomic conditions do not deteriorate significantly and barring any other unforeseeable adverse effects that have a material impact on the Balda Group, the company assumes that it will generate consolidated sales revenue in the EUR 70 million to EUR 80 million range, accompanied by a single-digit EBITDA margin and a profit. Earnings are strongly dependent on currency effects.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BALOF:US $3.77 USD 0.00

BALOF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hi-P International Ltd $0.70 SGD +0.01
Laird PLC 293.00 GBp +1.60
View Industry Companies

Industry Analysis


Industry Average

Valuation BALOF Industry Range
Price/Earnings 20.2x
Price/Sales 2.5x
Price/Book 0.7x
Price/Cash Flow 11.8x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BALDA AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at